HRS-1893 - Jiangsu Hengrui Pharma
A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants (clinicaltrials.gov) - Apr 18, 2026 - P1 | N=36 | Recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting 
Enrollment open • Cardiomyopathy • Cardiovascular
http://clinicaltrials.gov/ct2/show/NCT07479641
 
Apr 18, 2026
 
Prev Next